key: cord-0730772-v4spn75m
authors: Lee, Wing-Yiu Jason; Liang, Chen; Sloan, Richard D
title: IFITM proteins inhibit HIV-1 protein synthesis
date: 2017-10-11
journal: bioRxiv
DOI: 10.1101/201525
sha: 85396c94ae63a6eb29b34c779bf0924e15a66cf3
doc_id: 730772
cord_uid: v4spn75m

Interferon induced transmembrane proteins (IFITMs) inhibit the cellular entry of a broad range of viruses, but it has been suspected that for HIV-1 IFITMs may also inhibit a post-integration replicative step. We show that IFITM expression reduces HIV-1 viral protein synthesis by preferentially excluding viral mRNA transcripts from translation and thereby restricts viral production. Codon-optimization of proviral DNA rescues viral translation, implying that IFITM-mediated restriction requires recognition of viral RNA elements. In addition, we find that expression of the viral accessory protein Nef can help overcome the IFITM-mediated inhibition of protein synthesis. Our studies identify a novel role for IFITMs in inhibiting HIV replication at the level of translation, but show that the effects can be overcome by the lentiviral protein Nef. Importance Cells can protect themselves from infection by producing antiviral proteins that directly disrupt viral replication processes. The IFITM protein family has been identified to inhibit a wide range of viruses in this way, including HIV. Inhibition of HIV infection in cells by IFITM proteins is understood to occur due to a block in entry of viruses into cells, but also due to a reduction in the infectivity of virus particles produced in cells that express IFITMs. However, a third and additional block to HIV infection by IFITMs has been suspected. We show here that IFITM proteins specifically block viral protein production even after HIV enters target cells. Yet we also show that the virus can partially overcome this block by producing a countermeasure protein Nef. Therefore our data show that IFITM proteins are multifunctional antiviral proteins that can inhibit HIV through three distinct mechanisms – blocking viral entry, reducing virus infectivity, and inhibiting virus protein production.

Cells can protect themselves from infection by producing antiviral proteins that directly 24 disrupt viral replication processes. The IFITM protein family has been identified to inhibit 25 a wide range of viruses in this way, including HIV. Inhibition of HIV infection in cells by 26 IFITM proteins is understood to occur due to a block in entry of viruses into cells, but 27 also due to a reduction in the infectivity of virus particles produced in cells that express 28 IFITMs. However, a third and additional block to HIV infection by IFITMs has been 29 suspected. We show here that IFITM proteins specifically block viral protein production 30 even after HIV enters target cells. Yet we also show that the virus can partially 31 overcome this block by producing a countermeasure protein Nef. Therefore our data 32 Introduction 38 Viruses must replicate in cells; the consequence of such dependence is susceptibility. 39 Cells have thus evolved a series of antiviral factors that directly subvert viral replication. 40 screens can aid identification of further antiviral factors, and so there is an expanding 46 list being described [3, 4] . Such studies identified the MxB/Mx2 protein that targets HIV-1 47 replication around nuclear entry (3, 4), and the SERINC3 and SERINC5 proteins that 48 target HIV-1 entry (5, 6). 49 The interferon induced transmembrane proteins (IFITMs) have been similarly identified 50 in multiple independent screens as antiviral factors (7-10). Humans have three antiviral . 59 Yet since the discovery of their antiviral effect upon HIV-1, it was immediately apparent 60 that a viral replication step downstream of host genome integration might also be 61 inhibited by IFITM proteins, as IFITM1 knockdown increased HIV-1 titres from infected 62 CD4 + T-cells (8). In the same study, IFITM1 inhibited the replication of HIV-1 in T-cell 63 culture despite the evidence that IFITM1 had no effect on viral replication steps from cell 64 entry to host genome integration for the viral strain used. Other studies have also noted IFITMs inhibit HIV-1 protein synthesis 6 to a single round respectively. The quantity of wild type HIV-1 produced by expressing T-cells was inhibited across a range of viral inputs and was paired with 116 losses in viral protein levels (Figure 2 ), indicating that IFITMs inhibit viral production 117 independent of their effects on viral entry. 118 We next wished to investigate this effect using knockdown of endogenous IFITM levels, 119 and to assess the relative contribution of IFITMs towards inhibition of viral production 120 that is observed with type I interferon (IFN) treatment. We therefore analyzed viral Figure 3D and 3E). These data then show that endogenous levels of IFITMs can inhibit viral particle output and suggest that IFITMs are a significant 137 component of the antiviral response induced by type I interferon. 138 We next sought to confirm if the knockdown of physiologically relevant levels of IFITMs to the uptake of virus into potentially non-productive endocytic pathways, p24 uptake is 164 still found to be inhibited by IFITM expression (12, 13, 22, 23), while endocytic uptake of 165 virus occurs at a lower rate in primary CD4 + T-cells (30). We confirmed that viral uptake 166 was minimally impeded with these viruses during IFITM knockdown ( Figure 4A , B, G, 167 H), consistent with prior observations (26). Therefore reductions in virus production 168 were considered to arise predominantly from effects other than inhibition of viral entry. 169 We were thus able to determine that weak knockdown of IFITM1 yielded only a very 170 weak recovery of NL4-3 viral production (25%) and protein expression ( Figure 4C , D, 171 F). An effect was more readily detectable during knockdown of IFITM2, or IFITM1-172 IFITM3, as this led to a clear rescue of viral particle output (7-fold and >10-fold 173 respectively) that was coupled with rescue in viral protein expression ( Figure 4I , J, M).

This then confirms that physiologically relevant levels of IFITM proteins can clearly 175 inhibit HIV-1 production in primary cells independent of their effects upon entry and 176 infectivity, consistent with our observations in cell lines.

IFITMs restrict HIV-1 protein synthesis. 179 As we found that IFITM expression was associated with losses in viral protein 180 production and viral output, we next asked if IFITMs play a role in inhibiting the 181 transcription or stability of viral mRNA by analyzing the level of unspliced, singly-spliced, and multiply-spliced transcripts detected by RT-qPCR from total RNA of whole cell 183 lysates. IFITM1 and IFITM2 weakly reduced the levels of singly-spliced and multiply-184 spliced transcripts, while IFITM3 had no measureable effect ( Figure 5A ). The total level 185 of unspliced transcripts remained unaffected in the presence of IFITM proteins ( Figure   186 5A) but nonetheless there were reductions of intracellular level of Gag (a product of 187 unspliced transcripts) in our prior analyses (Figures 1-4) . This prompted us to 188 investigate if IFITM proteins affect translation of viral transcripts.

To achieve this we performed a polysome analysis for HIV-1 transcripts during IFITM of viral transcripts in selected fractions covering the whole RNA profile with RT-qPCR. 199 We used the level of ribosomal protein L7 as a guide for selection of fractions in our 200 analysis ( Figure 5D ) as it is a component of 60S ribosomes, which are enriched in 80S 201 monosomes (such as fraction 10 Figure 5D ) as well as polysomes (such as fractions 202 14-18, Figure 5D ). IFITM1 and IFITM2 significantly reduced the level of unspliced and We then sought to identify the specific RNA features that render HIV-1 susceptible to an 243 IFITM-driven translational block. As our findings of transfected HEK293T cells showed 244 that unspliced and singly-spliced viral transcripts are seemingly more readily excluded 245 from polysomes by IFITM proteins than multiply-spliced transcripts in those cells ( Figure   246 5), we reasoned that RRE, which is present in only unspliced and singly-spliced 247 transcripts may be somehow recognized due to IFITM protein expression leading to 248 translational inhibition. To address this, we exploited constructs in which singly-spliced 249 and unspliced transcripts had been rendered RRE and Rev independent via the 250 introduction of the Mason Pfizer Monkey Virus (MPMV) constitutive transport element (CTE) (34). A modification which allows all transcripts to be exported from the nucleus 252 by the cellular TAP/NXT1 pathway, rather than RRE bearing Rev-dependent transcripts 253 exporting via the CRM1 pathway (35). We found that CTE dependent Rev independent 254 virus was still inhibited by IFITM proteins (Figure 6G ), demonstrating at least that 255 nuclear export pathway does not affect the virus production inhibition seen with IFITM 256 proteins. Further introduction of the RRE into CTE bearing constructs did also not 257 augment the restriction. (1)). We 267 therefore sought to investigate if HIV is able to counteract the restriction of viral 268 production by IFITM proteins. We reasoned that HIV-1 Nef may influence this process. We therefore measured the level of virus production in HEK293T cells transfected with 274 expression vectors of IFITMs with wild type or nef-deleted HIV-1 NL4-3 proviral DNA.

The level of nef-deleted virus produced was inhibited 18-fold by IFITM1, 21-fold by 276 IFITM2 and 5-fold for IFITM3, suggesting a 4-fold enhancement of virus production due 277 to HIV-1 Nef during IFITM1 and IFITM2 expression ( Figure 7A ). We confirmed a 278 reduction in HIV-1 Gag levels in cells producing nef-deleted virus while IFITMs are 279 expressed ( Figure 7B ), indicating that Nef may rescue the translational suppression 280 driven by IFITMs. As these data were generated through transfection, they were 281 independent of any influence of Nef upon viral entry (5, 6). It is also of note that 282 exogenous IFITM levels were not reduced by HIV-1 Nef, perhaps indicating that 283 antagonism of IFITM proteins may not occur via degradation ( Figure 7B ). 284 We next investigated if Nef presented an advantage to viral growth in infected T-cells. 285 We infected SupT1 cells with either wild type or nef-deleted NL4-3 virus by post-entry 286 induction of IFITM expression via doxycycline ( Figure 7C ). As nef-deleted virus has an 287 inherent growth defect, we normalized the quantity of wild type and nef-deleted virus 288 produced from IFITM-induced cells to vector control cells. We chose to induce IFITMs 289 after viral entry and limit infections to a single round through the use of the (CXCR4 290 antagonist AMD3100) to mitigate the influence of IFITMs upon entry. In this regard, we 291 found that nef-deleted virus was no more susceptible to IFITM-mediated restriction of 292 entry than wild type virus ( Figure 7D ). Compared to wild type virus, production of nef-293 deleted virus in infected SupT1 cells was reduced significantly when IFITM1 expression 294 was induced (~2-fold), while a trend of similar magnitude was noted for IFITM2.

However there was no rescue of virus infection by Nef in IFITM3 expressing cells 296 ( Figure 7C ).

To further confirm the role of IFITM1 in suppressing virus production in T cells, we 298 monitored the production of either wild type or nef-deleted HIV-1 NL4-3 virus in multiple 299 cycle infections in a C8166 T-cell line transduced to constitutively over-express IFITM1.

As IFITM1 does not typically affect the entry of CXCR4-tropic virus ( Figure 4A , B and (8, 301 26)), any difference in replication measured between wild type and nef-deleted virus 302 could only arise from IFITM1-mediated effects on viral production, not cell entry.

Therefore this experiment was not pursued for IFITM2 and IFITM3, as their constitutive 304 expression would inhibit virus entry and complicate interpretation. We found that in the 305 presence of IFITM1, the growth of nef-deleted virus was significantly reduced relative to 306 wild type virus, with wild type virus showing 2-fold inhibition at 5 days post-infection, 307 while nef-deleted virus was inhibited 5-fold by IFITM1 ( Figure 7E ). Interestingly, the 308 benefit of Nef expression in the context of IFITM1 was lost in the later stages of viral 309 culture, when cell-to-cell infection typically predominates (41). As nef-deleted virus was 310 no more susceptible to IFITM-mediated restriction of entry than wild type virus ( Figure   311 7D), these findings are likely due to the influence of Nef to partially rescue virus 312 production as seen in 293T cell transfections and SupT1 infections. 313 We then investigated if Nef from other lentiviruses was able to overcome IFITM- can antagonize to this process as is seen for some antiviral restriction factors (reviewed 341 in (1)). 342 We have now advanced the understanding of this phenomenon by demonstrating the 343 breadth of the IFITM-mediated restriction of virus production, identifying the viral 344 replication process that is subverted, and determining a means by which HIV-1 may 345 partially overcome this effect. In addition, we find that restriction of viral production by 346 IFITM proteins is clear contributor towards the inhibition of HIV-1 production seen in 347 cells exposed to type I interferon, and have also shown that inhibition occurs in primary SIVs implies the phenotype we observe is likely not an artefact. This is supported by our 359 finding that African Green Monkey IFITM1 can exert a similar antiviral effect upon HIV-1 360 production as occurs with human IFITM1. Further work to fully define losses in viral 361 protein production for HIV-2 and SIVs will be of interest, particularly for HIV-2 ROD and 362 SIV AGM that showed some resistance in restriction relative to other viruses tested. In contrast, HIV-1 89.6 showed remarkable sensitivity to the restriction, and the molecular 364 basis of this is not yet known. It will also be of interest to explore if the restriction to virus 365 production is exerted by additional non-human IFITM alleles. 366 The general mechanism of restriction we outline is specific exclusion of HIV-1 mRNA 367 from polysomes during IFITM expression. In HEK293T cells the effect principally occurs 368 with IFITM1 and IFITM2, but less so for IFITM3 was generally consistent throughout our inhibition. Thus future work to determine the parameters regulating the activity of the 382 antiviral process we describe will be of value. However, it is important to note that we 383 were able to clearly confirm the inhibition of viral production in primary human CD4 + T- Though how such a process could be specific to virus translation is unclear. 443 We demonstrated that the lentiviral protein Nef can help overcome the late-stage (37, 38, 58, 59) . However, a second possibility is that due to the influence of Nef 457 on NFkB activity, viral transcription may be stimulated to a level that can saturate the 458 late-stage viral inhibition exerted by IFITM proteins (60). 459 We also found that, in multiple cycle infections, the benefit of Nef expression was only 496 The following antibodies were used to detect IFITMs: human IFITM1 (clone 5B5E2, and rabbit polyclonal anti-HIV1 Gag (Abcam) were used to detect viral proteins. As 

In the presence of CD3/CD28 T-cell activator beads, 5x10 5 /ml activated CD4 + T cells 545 were transduced with IFITM-targeting or scrambled shRNA lentivirus with p24 at 100ng/ml for 2 hours at 1000 xg, 37°C and then for 1 hour incubation. Infected cells 547 were washed three times with PBS, re-suspended in complete medium with 30U/ml IL-2 548 and then incubated at 37°C for 48 hours. Prior to HIV infection, T cell activator beads 549 were removed from transduced CD4 + T cells. Transduced CD4 + T cells were then 550 incubated with medium alone, 5µM Maraviroc or 5µM AMD3100 for 2 hours at 37°C. from Sigma) and 800U/ml RNase OUT (ThermoFisher), for 10 minutes on ice. Cell lysate was centrifuged at 10, 000x g for 1 minute at 4°C and supernatant was then 593 adjusted to 200µg/ml cycloheximide and 700µg/ml heparin (Sigma). Following 594 centrifugation at 12, 000x g for 10 minutes at 4°C, an aliquot of supernatant was taken 595 as input and the rest was layered onto a 10% to 50% sucrose gradient prepared using 596 polysomal buffer. Gradients were then ultracentrifuged at 300,000x g for 16 hours at 

HIV Restriction Factors and Mechanisms of 657

Intrinsic host restrictions to HIV-1 and JU. 2013. The Antiviral Effector IFITM3 Disrupts Intracellular Cholesterol 702 Homeostasis to Block Viral Entry

IFITM Proteins Restrict HIV-1 Infection by 705 Antagonizing the Envelope Glycoprotein

Distinct patterns 709 of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A 710 virus

IFITM1 is a tight junction protein that 713 inhibits hepatitis C virus entry

The IFITMs Inhibit Zika Virus Replication

Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral 718

Identification of Interferon-Stimulated Genes 721 with Antiretroviral Activity

Natural mutations in IFITM3 modulate post-translational 724 regulation and toggle antiviral specificity

HIV-1 mutates to evade IFITM1 726 restriction

Characteristics of IFITM, the newly identified IFN-729 inducible anti-HIV-1 family proteins

index of productive entry of human immunodeficiency virus type 1

Productive entry of HIV-1 during cell-to-cell transmission via dynamin-dependent 741 endocytosis

Cell-cell spread of human immunodeficiency 743 virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells

Inhibition of HIV-1 endocytosis allows lipid mixing at the 747 plasma membrane, but not complete fusion

HIV-1 blocks 751 the signaling adaptor MAVS to evade antiviral host defense after sensing of 752 abortive HIV-1 RNA by the host helicase DDX3

Continuous high-titer HIV-1 vector production

A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based 757 vector that exploits a codon-optimized HIV-1 gag-pol gene

Global changes in the RNA binding specificity of HIV-1 gag 760 regulate virion genesis

The constitutive transport element 763 (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export 764 pathway

HIV-1 Nef and Vpu are functionally redundant broad-spectrum 776 modulators of cell surface receptors, including tetraspanins

Human Immunodeficiency Virus Type 1F12 Inhibits Viral Production and 780

The primate lentivirus-encoded Nef protein can 782 regulate several steps of the viral replication cycle

An in vitro rapid-turnover assay 784 for human immunodeficiency virus type 1 replication selects for cell-to-cell spread 785 of virus

Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that 790 gave rise to HIV-1

The function and evolution of the 792 restriction factor Viperin in primates was not driven by lentiviruses

S-palmitoylation and ubiquitination 795 differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-796 mediated resistance to influenza virus

The N-798 terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 799 cellular localization

3 independent experiments and differences were assessed by Student's t-1005 test, * denotes p<0